Publications by authors named "Christopher Kirkegaard Torp"
Introduction: Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is a relatively new disease entity caused by ICI agents during cancer therapy. Reactive arthritis (ReA) is a well-known disease entity caused by urogenital or gastrointestinal bacterial infection or pneumonia. In this sense, ICI-IA and ReA are both defined by a reaction to a well-specified causal event.
View Article and Find Full Text PDFArticle Synopsis
- The primary vasculitides are a diverse group of immune-related diseases categorized by the size of the affected blood vessels, with recent studies exploring more specific immunological mechanisms.
- A systematic review of 40 studies revealed the efficacy of various biologic therapies, such as tocilizumab for large vessel vasculitis and rituximab for granulomatosis with polyangiitis and microscopic polyangiitis.
- Findings indicate that targeting specific cytokines and cellular mechanisms can help refine the classification of vasculitis and may lead to distinct treatment approaches based on disease subtype.